NanoViricides announces Phase II clinical trial registration for NV-387 oral gummies to treat Ebola in the Democratic Republic of Congo amid the largest outbreak.
NanoViricides announces Phase II clinical trial for oral Ebola drug NV-387 registered in Pan African database, ready to treat patients amid growing DRC outbreak.
SHELTON, CT / ACCESS Newswire / September 8, 2026 / , Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, announces that its Phase ...
Given its speed, scale and scope, the Bundibugyo Ebola virus disease that broke out in the Democratic Republic of Congo in ...
Byron Donalds linked U.S. measles outbreaks to illegal immigration. On CBS News' "Face the Nation" on Aug. 23, host Margaret Bre ...
The ancient statues of the deities Heket and Beset, too heavy to move, were used for target practice.
The Learn Cornish podcast was launched in May with BBC Radio 1's Danni Diston presenting.
Kazakhstan to see rain and thunderstorms over next 3 days. . Unsettled weather with rain, thunderstorms and strong w ...
Freight volumes along the Trans-Caspian International Transport Route (TITR) increased by 22% in the first eight months of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results